Date: 2024/11/03 - 00:50
A new study explores the role of dysfunctioning mitochondria and a disrupted gut microbiome as a possible trigger of Crohn's disease.
Standing more does not improve heart health compared with sitting and may increase a person's risk for circulatory issues such as deep vein thrombosis and varicose veins, a new study finds.
Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, also sends Crohn's disease into clinical remission, new findings suggest.